Theragenics plans to lay off 23 workers as it concentrates on its core cancer products and its newly acquired CP Medical, which makes medical devices. Theragenics will discontinue programs for macular degeneration, breast cancer and more. The company says it is looking to its business operations that have the best potential for generating revenue.
- read this AP story for more